Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-08-23
2005-08-23
Carlson, Karen Cochrane (Department: 1653)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S350000
Reexamination Certificate
active
06933273
ABSTRACT:
The present invention provides isolated laminin 10, methods for making recombinant laminin 10, host cells that express recombinant laminin 10, and methods for using the recombinant laminin 10 to accelerate the healing of injuries to vascular tissue, and to promote cell attachment and migration. The present invention also provides nucleic acid sequences encoding full length human laminin α5 chain, expression vectors and host cells thereof, and isolated full length human laminin α5 polypeptide chain.
REFERENCES:
patent: WO 00/66730 (2000-11-01), None
patent: WO 00/66731 (2000-11-01), None
patent: WO 00/66732 (2000-11-01), None
Sasaki et al. 1987. P.N.A.S. 84: 935-939.
Pikkarainen et al. 1987.J. Biol. Chem 262:10454-10462.
Sasaki et al. 1987. J. Biol. Chem 262: 17111-17117.
Pikkarainen et al. 1988.J. Biol. Chem 263:6751-6758.
Altschul, et al., (1990),J. Mol. Biol.,215:403-410.
Altschul, et al., (1997),Nucleic Acids. Res.,25:3389-3402.
Aumailley and Kreig, (1996),J. Invest. Dermatology,106:209-214.
Aumailley, et al., (1996), In The Laminins, Timpl and Ekblom, eds., Harwood Academic Publishers, Amsterdam, 127-158.
Aumailley, M., and Smyth, N., (1998),J. Anat.,193(Pt 1): 1-21.
Champliaud, MF, et al., (2000),Experiment Cell Research,259(2): 326-35.
Church, HJ, et al., (1998),Biochemical Journal,332(2): 491-8.
Clark, E. A. et al., (1995),Science,268(5208): 233-9.
Cleland, et al., (1993),Crit. Rev. Therapeutic Drug Carrier Systems,10:307-377.
Colognato, J., (1999),J. Cell Biol.,145:619-631.
Davis, G. E., et al., (1995),Exp. Cell Res.,216(1): 113-23.
De Arcangelis, A., et al., (2001),International Journal of Cancer,94(1): 44-53.
Dejana, E., et al., (1993),Kidney Int.,43(1): 61-5.
Dixit, P., et al., (2001),J. Biomed. Mater. Res.,56(4): 545-55.
Durkin, ME, (1997),FEBS Letters,411(2-3): 296-300.
Durkin, ME, “Homo sapiens laminin, alpha 5(LAMA5),MRNA,”Accession No. NM005560, May 30, 2001.
Eble, JA, (1998),Biochemistry,37(31): 10945-55.
Ekblom, M., Flak, M., (1998),Annals of the New York Academy of Sciences,857:194-211.
El Nemer, W., et al., (2001),Journal of Biological Chemistry,276(26): 23757-62.
Engel, J., (1994), MethodsEnzymol.,245:469-88.
Faury, Ristori, G., et al., (1995),Journal of Vascular Research,32(2): 112-9.
Ferletta, M. et al., (1999),J. Cell Sci.,112(Pt. 1): 1-10.
Frojdman, K., et al., (1999),Differentiation,64(3): 151-9.
Fujiwara, H., et al., (2001),J. Biol. Chem.,276(20): 17550-8.
Geberhiwot, T., et al., (2001),Journal of Cell Science,114(Pt. 2): 423-33.
Goodwin, AE, et al., (1995),Journal of Immunological Methods,187(2): 213-9.
Gu, J., (2001),Journal of Biological Chemistry,276(29): 27090-7.
Gu, Y., et al., (1999),Blood,93(8):2533-42.
Haegerstrand, A., et al., (1992),J. Vasc. Surg.,16(2): 280-5.
Hellivwell, TR, et al., (1998),Neuromuscular Disorders,8(3-4): 152-61.
Hunter, D.D., et al., (1989),Cell,59(5): 905-13.
Iivanainen, A., et al., (1997),J. Biol. Chem.,272(44): 27862-8.
Jansson, K., et al., (1998),Eur. J. Vasc. Endovasc. Surg.,16(4): 334-41.
John, St., PL, et al., (2001),Kidney International,60(3): 1037-46.
Kamiguchi, et al., (1998),Ann. Rev. Neurosci.,21:97-125.
Kanda, S., et al., (1999),Exp. Cell Res.,248(1): 203-13.
Karlin and Altschul, (1990),Proc. Natl. Acad. Sci. USA,87:2264-2268.
Karlin and Altschul, (1993),Proc. Natl. Acad. Sci USA,90:5873-5877.
Kikkawa, Y., et al., (1998),J. Biol. Chem.,273(25): 15854-9.
Kikkawa, Y., et al., (2000,J. Cell Sci.,113(Pt. 5): 869-76.
Kohler and Milstein, (1975),Nature,256:495-497.
Kortesmaa, J. et al., (2000),J. Biol. Chem.,275(20): 14853-9.
Kozak, M., (1991),J. Cell Biol.,115(4): 997-903.
Lallier, T., et al., (1991),Development,113(4): 1069-84.
Lange, TS, et al., (1994),Experimental Cell Research,214(1): 381-8.
Ling, A. Dai, et al., (1999),Hypertension,34(5): 1141-6.
Lin, L., et al., (2000),Experimental Eye Research,70(4): 537-46.
Ljubimov AV, et al., (1998),Journal of Histochemistry&Cytochemistry,46(9): 1033-41.
Madri, J.A., et al., (1988),Am. J. Pathol.,132(1):18-27.
Madri, J.A., et al., (1991),J. Cell Biochem.,45(2):123-30.
Malinda and Kleinman, (1996), Cell Biol.,Int. J. Biochem,28:957-959.
Miner, J.H., et al., (1995),J. Biol. Chem.,270(48): 28523-6.
Miner, J.H., et al., (1997),J. Cell Biol.,137(3): 685-701.
Miner, J.H. et al., “Mus Musculus laminin alpha 5 chain (Lama5) MRNA, partial cds.,” Accession No. U37501, Nov. 10, 1997.
Miner, J.H., et al., (1998),J. Cell Biol.,143(6): 1713-23.
Miner, J.H., et al., (2000),Dev. Biol.,217(2): 278-89.
Nielsen, P.K., et al., (2000),Journal of Biological Chemistry,275(19): 14517-23.
Nielsen, P.K., et al., (2001),J. Biol. Chem.,276(14): 10906-12.
Parsons, SF, et al., (2001),Blood,97(1): 312-20.
Patton, B. L., et al., (1997),J. Cell Biol.,139(6): 1507-21.
Pedraza, C. Gerberhiwot, (2000),Journal of Immunology,165(10): 5831-8.
Pevec, W. C., et al., (1992),J. Vasc. Surg.,16(1): 60-5.
Pierschbacher, M.D., et al., (1984),Nature,309(5963): 30-3.
Pikkarainen, T., et al., (1992),Eur. J. Biochem.,209(2):571-82.
Pinckard, et al., (1967),Clin. Exp. Immunol.,2:331-340.
Pouliot, N., et al., (2000),Experimental Cell Research,261(2): 360-71.
Pouliot, N., et al., (2001),Exp. Cell Res.,266(1), 1-10.
Robbins, et al., (1987),Diabetes,36:838-845.
Sanes, JR., et al., (1998),Journal of Physiology,92(3-4): 167-72.
Seebacher, T., et al., (1997),Experimental Cell Research,237(1): 70-6.
Shah, BH, et al., (1992),Brain Research,589(2): 268-74.
Shattil, S.J., et al., (1997),J. Clin. Invest.,100(11 Suppl), S91-5.
Siler, U., Seiffert M., (2000),Blood,96(13): 4194-203.
Sixt, M., (2001),Journal of Cell Biology,153(5): 933-46.
Sixt, M., et al., (2001),J. Biol. Chem.,276(22), 18878-87.
Skelton, HG, (1998),American Journal of Dermatopathology,20(6): 547-50.
Sorokin, L. M., et al., (1997),Dev. Biol.,189(2): 285-300.
Sorokin, L. M., et al., (1997),Dev. Dyn.,210(4):446-62.
Sorokin, L., et al., (1994),Eur. J. Biochem.,223(2):603-10.
Spessotto, P. Yin, et al., (2001),Cancer Research,61(1): 339-47.
Tani, T., et al., (1999),Exp. Cell Res.,248(1): 115-21.
Timpl, R., and Brown, J.C., (1994),Matrix Biol.,14(4): 275-281.
Tokida, Y., et al., (1990),J. Biol. Chem.,265(30): 18123-9.
Vanderboom, RJ, et al., (1989),Journal of Reproduction&Fertility,87(1): 81-7.
Varani, J., et al., (1995),Journal of Biomedical Materials Research,29(8): 993-7.
Virtanen, I., et al., (1997),Am. J. Pathol.,150(4):1421-31.
Wang, YG, Samarel, et al., (2000),Journal of Physiology,526(Pt. 1): 57-68.
Watelet, J., et al., (1997),Ann. Vasc. Surg.,11(5): 510-9.
Wayner, E.A., et al., (1993),J. Cell Biol.,121(5): 1141-52.
Wewer and Engvall, (1996),Neuromusc. Disord.,6:409-418.
Woerly, S., et al., (1996),Neuroscience Letters,205(3) 197-201.
Yurchenco, et al., (1997),Proc. Natl. Acad. Sci.,94:10189-10194.
Doi Masayuki
Thyboll Jill
Tryggvason Karl
Carlson Karen Cochrane
McDonnell Boehnen & Hulbert & Berghoff LLP
LandOfFree
Isolated laminin 10 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Isolated laminin 10, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Isolated laminin 10 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3477348